KLF9 and breast cancer: First, Kleppel-like factor-9 (KLF9) can recruit HDAC1 to reduce the level of acetylation at the binding site of KLF9 to the matrix metallopeptidase 9 (MMP9) promoter, thereby inhibiting the invasion and migration of breast cancer cells [95].